Associations between Hyponatremia Correction and Survival Rate in Hospitalized Lung Cancer Patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20200106001

Enrollment

200

Registered

2020-01-06

Start date

2020-01-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyponatremia in lung cancer patients Hyponatremia correction Lung cancer

Interventions

Hospitalized lung cancer patients who documented hyponatremia (serum sodium 135 mmol/L as a time&#45

varying variable.

Treatment

Lung cancer patients with hyponatremia

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age of 18 years or older Hospitalized lung cancer patients Serum sodium levels <135 mmol/L

Exclusion criteria

Exclusion criteria: 1) Patients death within 72 hours after first admission 2) Patients with concomitant hepatitis B virus, hepatitis C virus or human immunodeficiency virus (HIV) infection 3) Patients with serum creatinine >3.0 mg/dL 4) Patient with blood pressure <90/60 mmHg

Design outcomes

Primary

Measure	Time frame
Patient mortality Patients were followed until death or until the last visit Vital status was confirmed by Department of Provincial Administration, Ministry of Interior	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactKajohnsak Noppakun

Chiang Mai University

kajohnsak.noppakun@cmu.ac.th66-81-5953465

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026